Showing 1,539 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental HIV treatments

GSK's new once-daily HIV drug matches Merck rival

Editor's pick
Reuters
2 April 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study

Editor's pick
ViiV Healthcare (press release)
2 April 2012
Access to healthcare

Brazil HIV Drug Patent Ruling Allows Generics, Sends Pipeline Process Into Doubt

Editor's pick
Intellectual Property Watch
23 March 2012
Pharmaceutical industry

Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company

Editor's pick
Abbott press release
23 March 2012
New & experimental HIV treatments

Avexa closer to EMA approval for ATC

Editor's pick
Australian Life Scientist
23 March 2012
Hepatitis C transmission & prevention

Former Merck Unit Works on First Vaccine for Hepatitis C

Editor's pick
Bloomberg Business Week
22 March 2012
Cancer

Curing cancer: how genomics is speeding up research

Editor's pick
Financial Times
20 March 2012
Pharmaceutical industry

FDA Swayed By Politics & Industry: FDA Scientists

Editor's pick
Pharmalot
15 March 2012
The search for an HIV prevention vaccine

Inovio Pharmaceuticals' PENNVAX®-B HIV Vaccine Demonstrates Strong T-Cell Immune Responses in Therapeutic Vaccine Trial

Editor's pick
Manual Items
14 March 2012
Access to healthcare

India's patent ruling on cancer may open door for cheaper HIV drugs

Editor's pick
Times of India
13 March 2012
New & experimental hepatitis C treatment

NICE recommends Victrelis in speedy review

Editor's pick
InPharm
9 March 2012
New & experimental HIV treatments

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

Editor's pick
The Body
9 March 2012
New & experimental HIV treatments

Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study

News
8 March 2012
Pharmaceutical industry

New Greek law says industry must cover pharma overspend

Editor's pick
Pharma Times
8 March 2012
New & experimental HIV treatments

Gilead's Quad Single Tablet Regimen For HIV Non-Inferior To Atripla In Study

Editor's pick
NASDAQ
7 March 2012
Access to healthcare

Why global health activists are fired up about Novartis

Editor's pick
Science Speaks
27 February 2012
Access to healthcare

UNAIDS Executive Director calls for greater local production of HIV medicines in Ghana

Editor's pick
Myjoyonline.com
27 February 2012
Access to healthcare

Outcry from African NGOs over Cape Town intellectual property summit

Editor's pick
Key Correspondents
27 February 2012
Side effects

FDA Pain Patch Decision: Making a 'Sophie's Choice' with People's Lives

Editor's pick
HIVandHepatitis.com
20 February 2012
New & experimental hepatitis C treatment

Gilead Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study

Editor's pick
Gilead press release
17 February 2012
New & experimental hepatitis C treatment

Gilead Drops as Patients Relapse on Hepatitis C Drug

Editor's pick
Bloomberg Business Week
17 February 2012
Adherence

New 'smart pills' signal your iPhone

Editor's pick
Eurekalert Medicine & Health
15 February 2012
New & experimental hepatitis C treatment

Drugmakers Jockey for Piece of Future Hepatitis C Combo Pill

Editor's pick
Bloomberg Business Week
15 February 2012
PrEP

Gilead: FDA Fast Tracks Review Of HIV Drug Truvada

Editor's pick
Wall Street Journal
14 February 2012